farnesol has been researched along with staphyloxanthin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroda, M; Nagasaki, S; Ohta, T | 1 |
| Bruno, V; Ibrahim, A; Jabra-Rizk, MA; Kong, EF; McCracken, C; Piepenbrink, K; Shetty, AC; Vila, T | 1 |
2 other study(ies) available for farnesol and staphyloxanthin
| Article | Year |
|---|---|
Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus.
Topics: beta-Lactamases; beta-Lactams; Biological Transport; Cell Wall; Farnesol; Methicillin Resistance; Mevalonic Acid; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Peptidoglycan; Polyisoprenyl Phosphates; Staphylococcus aureus; Xanthophylls | 2007 |
Topics: Biofilms; Candida albicans; Farnesol; Microbial Interactions; Oxidative Stress; Quorum Sensing; Staphylococcal Infections; Staphylococcus aureus; Virulence; Virulence Factors; Xanthophylls | 2019 |